Esperion Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -21.2% | -99.3% | -0.1% | +0.1% | +87.4% | +11,434.6% | -98.2% | +151.4% | -17.2% | +409.6% | -64.6% | +6.9% | +22.3% | +0.0% | +0.7% | -0.9% | +29.3% | +6.0% | +31.7% | -5.1% | +327.1% | -46.4% | -30.1% | +33.9% | -6.0% | +26.8% | +6.0% | +92.9% | -52.4% | – | |
| – | – | – | – | – | – | – | -72.3% | -3.5% | +5.1% | +19.1% | -6.4% | -7.6% | +12.8% | -20.8% | -99.9% | +1,183.9% | -30.9% | +513.8% | +5.7% | +0.9% | +208.8% | -8.7% | +40.4% | +28.8% | -29.1% | -36.1% | +180.1% | -41.8% | +97.1% | -14.4% | -12.0% | +54.9% | +10.7% | +48.3% | +23.0% | -9.5% | +94.2% | -49.7% | +24.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -26.6% | -142.2% | – | – | – | +11,610.2% | -98.3% | +123.4% | -22.1% | +527.4% | -77.2% | +16.7% | +13.4% | -17.5% | +29.1% | +17.5% | -13.5% | +49.9% | +8.4% | +1.0% | +513.8% | -54.4% | -41.0% | +26.6% | -23.1% | +60.9% | -40.8% | +340.9% | -67.6% | – | |
| – | +39.2% | +84.3% | +44.1% | +6.7% | +4.7% | -16.5% | +22.4% | -3.5% | +5.1% | +19.1% | -6.4% | -7.6% | +12.8% | -20.8% | -9.2% | +0.8% | +0.8% | +18.9% | -33.4% | -10.3% | +1.0% | +9.0% | -11.9% | +33.4% | -10.1% | +13.3% | -5.0% | -29.6% | -32.6% | +19.2% | -24.5% | -14.5% | -9.3% | +5.6% | +14.4% | -42.4% | +95.2% | -1.5% | -35.5% | – | |
| – | -9.0% | +4.5% | +14.2% | +7.6% | +5.0% | -7.5% | +13.3% | +16.8% | +29.5% | +24.0% | +9.0% | +10.8% | +36.9% | +17.6% | +91.4% | +14.7% | +2.4% | -14.9% | +51.2% | -26.3% | -3.2% | -45.0% | +52.2% | +3.4% | -35.7% | -48.6% | +223.7% | -1.9% | -18.4% | -10.3% | +40.8% | +5.2% | -9.5% | -71.4% | +276.3% | -8.1% | +5.9% | -1.0% | +4.1% | – | |
| – | +23.6% | +65.3% | +39.6% | +6.8% | +4.8% | -15.4% | +21.2% | -0.9% | +8.8% | +19.9% | -3.6% | -3.8% | +18.6% | -10.2% | +27.2% | +8.4% | +1.7% | +23.1% | -14.0% | -19.8% | -9.5% | +2.1% | -17.1% | +13.4% | -12.8% | +5.7% | +7.2% | -8.5% | -14.2% | +31.3% | -12.3% | +0.5% | -9.5% | -4.9% | +16.0% | -15.9% | -10.5% | +32.3% | -5.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -163.6% | – | – | – | – | -162.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -96.4% | -721.4% | – | – | – | -240.4% | – | -107.7% | – | |
| – | -10.1% | -12.4% | -14.1% | -17.9% | -20.0% | -27.3% | +31.3% | +0.0% | +0.0% | +0.0% | +9,414.3% | +0.0% | +0.0% | +3.2% | +1.1% | +11.2% | +6.2% | +81.2% | -9.0% | +37.2% | +22.5% | -1.6% | +4.7% | +1.5% | -0.8% | +1.2% | +0.4% | +1.0% | +3.2% | +0.4% | -6.9% | -2.1% | +9.9% | +8.9% | +18.3% | +5.4% | +7.6% | +2.7% | -12.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -162.1% | – | – | – | – | -168.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -201.5% | – | – | – | – | – | – | -139.6% | – | |
| – | -1.2% | -13.3% | +13.9% | -10.2% | +40.0% | +33.2% | -100.0% | – | – | – | – | – | – | -4.0% | -12.1% | +4.0% | +5.3% | +77.0% | -7.5% | +37.0% | +22.5% | -1.7% | +2.3% | +1.5% | -3.3% | -3.9% | +112.0% | -100.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -162.1% | – | – | – | – | -168.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -201.5% | – | – | – | – | – | – | -140.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -162.3% | – | – | – | – | -162.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -164.2% | – | – | – | – | -218.8% | – | -152.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.